Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients.
Bird ST, Smith ER, Gelperin K, Jung TH, Thompson A, Kambhampati R, Lyu H, Zhao H, Zhao Y, Zhu Y, Easley O, Niak A, Wernecke M, Chillarige Y, Zemskova M, Kelman JA, Graham DJ. Bird ST, et al. Among authors: kelman ja. JAMA. 2024 Feb 13;331(6):491-499. doi: 10.1001/jama.2023.28239. JAMA. 2024. PMID: 38241060 Free PMC article.
Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.
Graham DJ, Reichman ME, Wernecke M, Hsueh YH, Izem R, Southworth MR, Wei Y, Liao J, Goulding MR, Mott K, Chillarige Y, MaCurdy TE, Worrall C, Kelman JA. Graham DJ, et al. Among authors: kelman ja. JAMA Intern Med. 2016 Nov 1;176(11):1662-1671. doi: 10.1001/jamainternmed.2016.5954. JAMA Intern Med. 2016. PMID: 27695821
Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service Medicare.
Wang C, Kane R, Levenson M, Kelman J, Wernecke M, Lee JY, Kozlowski S, Dekmezian C, Zhang Z, Thompson A, Smith K, Wu YT, Wei Y, Chillarige Y, Ryan Q, Worrall C, MaCurdy TE, Graham DJ. Wang C, et al. JAMA Intern Med. 2016 Dec 1;176(12):1818-1825. doi: 10.1001/jamainternmed.2016.6520. JAMA Intern Med. 2016. PMID: 27775769
Dabigatran Compared With Rivaroxaban vs Warfarin-Reply.
Graham DJ, Wernecke M, Kelman JA. Graham DJ, et al. Among authors: kelman ja. JAMA Intern Med. 2017 May 1;177(5):743-744. doi: 10.1001/jamainternmed.2017.0567. JAMA Intern Med. 2017. PMID: 28460105 No abstract available.
Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia: A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicare Beneficiaries.
Bird ST, Tian F, Flowers N, Przepiorka D, Wang R, Jung TH, Kessler Z, Woods C, Kim B, Miller BW, Wernecke M, Kim C, McKean S, Gelperin K, MaCurdy TE, Kelman JA, Graham DJ. Bird ST, et al. Among authors: kelman ja. JAMA Oncol. 2020 Feb 1;6(2):248-254. doi: 10.1001/jamaoncol.2019.3994. JAMA Oncol. 2020. PMID: 31855259 Free PMC article. Clinical Trial.
Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population.
Kozlowski S, Flowers N, Birger N, Wernecke M, MaCurdy TE, Kelman JA, Graham DJ. Kozlowski S, et al. Among authors: kelman ja. J Gen Intern Med. 2021 Jul;36(7):2170-2173. doi: 10.1007/s11606-020-05957-1. Epub 2020 Jun 23. J Gen Intern Med. 2021. PMID: 32578017 Free PMC article. No abstract available.
122 results